ConductScience.org, home

Paper39475618

Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments.

Kennedy PR and 22 others. Sci Adv, 2024. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments. Papers, record 39475618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39475618

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments.
PubMed
Journal
Sci Adv
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
5.9, provisional
iCite
Revised in PubMed
2026-07-26
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

See all 23 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
Tumor MicroenvironmentMajor topic
Interleukin-15Major topic
NeoplasmsMajor topic
Humans
Cytotoxicity, Immunologic
Cell Line, Tumor
Signal Transduction
Cell Hypoxia

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R35 CA283892NCI NIH HHSUnited StatesR35CA283892PubMed and NIHNIH RePORTER
P30 CA077598NCI NIH HHSUnited StatesP30CA077598PubMed and NIHNIH RePORTER
R37 AI034495NIAID NIH HHSUnited StatesR37AI034495PubMed and NIHNIH RePORTER
T35 AI118620NIAID NIH HHSUnited StatesT35AI118620PubMedNIH RePORTER
P01 CA111412NCI NIH HHSUnited StatesP01CA111412PubMed and NIHNIH RePORTER
P01 HL158505NHLBI NIH HHSUnited StatesP01HL158505PubMed and NIHNIH RePORTER
R01 AG069781NIA NIH HHSUnited StatesR01AG069781PubMed and NIHNIH RePORTER
R01 DK091538NIDDK NIH HHSUnited StatesR01DK091538PubMed and NIHNIH RePORTER
T32GM133393NIHNIH RePORTER

Download CSV of grants

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127655849Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.Sci Transl Med2016https://conductscience.org/library/papers/27655849PubMed
227118044Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?Exp Hematol2016https://conductscience.org/library/papers/27118044PubMed
313130303Targeting HIF-1 for cancer therapy.Nat Rev Cancer2003https://conductscience.org/library/papers/13130303PubMed
424043259High interstitial fluid pressure promotes tumor cell proliferation and invasion in oral squamous cell carcinoma.Int J Mol Med2013https://conductscience.org/library/papers/24043259PubMed
534257622Hypoxia Signaling in Cancer: From Basics to Clinical Practice.Pathol Oncol Res2021https://conductscience.org/library/papers/34257622PubMed
626873994Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.J Immunol2016https://conductscience.org/library/papers/26873994PubMed
730938977Targeted Determination of Tissue Energy Status by LC-MS/MS.Anal Chem2019https://conductscience.org/library/papers/30938977PubMed
818855142The mechanical environment of bone marrow: a review.Ann Biomed Eng2008https://conductscience.org/library/papers/18855142PubMed
932695845Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/32695845PubMed
1038892084Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.Int J Mol Sci2024https://conductscience.org/library/papers/38892084PubMed
1117536958Detection and characterization of tumor hypoxia using pO2 histography.Antioxid Redox Signal2007https://conductscience.org/library/papers/17536958PubMed
1212160140Change of oxygen pressure in glioblastoma tissue under various conditions.J Neurooncol2002https://conductscience.org/library/papers/12160140PubMed
1331477722Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome.Nat Commun2019https://conductscience.org/library/papers/31477722PubMed
1434077737Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function.Cell Rep2021https://conductscience.org/library/papers/34077737PubMed
1527129235Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities.J Biol Chem2016https://conductscience.org/library/papers/27129235PubMed
1633782423STAT3 governs the HIF-1α response in IL-15 primed human NK cells.Sci Rep2021https://conductscience.org/library/papers/33782423PubMed
1722279576Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.PLoS One2012https://conductscience.org/library/papers/22279576PubMed
1833431318Generating natural killer cells for adoptive transfer: expanding horizons.Cytotherapy2021https://conductscience.org/library/papers/33431318PubMed
1934138753Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.J Clin Invest2021https://conductscience.org/library/papers/34138753PubMed
2031624330Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells.Sci Rep2019https://conductscience.org/library/papers/31624330PubMed

See all 100 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42909080Trifunctional antibody fusion proteins for targeted co-delivery of 4-1BBL with IL-15 or IL-21 to enhance antitumor immune responses.Front Immunol2026https://conductscience.org/library/papers/42909080PubMed
42807291Immunosuppressive tumor microenvironment and immunotherapy resistance of esophageal carcinoma.Front Immunol2026https://conductscience.org/library/papers/42807291PubMed
42769371Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases.MedComm (2020)2026https://conductscience.org/library/papers/42769371PubMed
42756298Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.Research (Wash D C)2026https://conductscience.org/library/papers/42756298PubMed
42713156Decoding the tumor microenvironment of triple-negative breast cancer: from immune evasion to precision immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42713156PubMed
42540267The Potential of AI-Driven High-Content Imaging in Drug Discovery.ACS Omega2026https://conductscience.org/library/papers/42540267PubMed
42510713Natural Killer Cell Immunotherapy in Solid Tumors: Microenvironmental Obstacles and Translational 3D Models.Biology (Basel)2026https://conductscience.org/library/papers/42510713PubMed
42346099The Architecture of Immune Escape in Neuroblastoma: Plasticity, Silence and Escape Engineer Immune Blindness.Cells2026https://conductscience.org/library/papers/42346099PubMed
42273671Bridging aging and colorectal cancer: synergistic roles of inflammaging and immunosenescence.Front Immunol2026https://conductscience.org/library/papers/42273671PubMed
42242227HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo.Cell Rep Med2026https://conductscience.org/library/papers/42242227PubMed
42233035Tumor immune microenvironment in non-small cell lung cancer progression.Front Immunol2026https://conductscience.org/library/papers/42233035PubMed
42079032Hypoxic tumor microenvironment and immune cell dynamics: From metabolic reprogramming to therapeutic innovation.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42079032PubMed
42033573Progress in cell-based immunotherapies for solid tumors.Discov Oncol2026https://conductscience.org/library/papers/42033573PubMed
42006290Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia.iScience2026https://conductscience.org/library/papers/42006290PubMed
41925950Mapping research trends in immune cell metabolic reprogramming in breast cancer: a parallel dual-database bibliometric study.Discov Oncol2026https://conductscience.org/library/papers/41925950PubMed
41764546Targeting metabolic reprogramming to enhance adoptive immunotherapy: emerging mechanisms and translational perspectives.J Transl Med2026https://conductscience.org/library/papers/41764546PubMed
41744817Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors.Cells2026https://conductscience.org/library/papers/41744817PubMed
41706678DRP1 depletion protects NK cells from hypoxia-induced dysfunction.Redox Rep2026https://conductscience.org/library/papers/41706678PubMed
41511303CAR-NK Engineering to Overcome TME Barriers.Cells2025https://conductscience.org/library/papers/41511303PubMed
41463052Lactate-Mediated Epigenetic and Immunometabolic Reprogramming in Glioma: An Emerging Axis Linking Metabolism to Tumor Progression.Biomedicines2025https://conductscience.org/library/papers/41463052PubMed

See all 34 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39475618

GET https://conductscience.org/api/papers/v1/39475618/authors?page=2